Re-evaluating the evidence for fecal microbiota transplantation “super-donors” in inflammatory bowel disease
Preprint
Abstract
SUMMARY: Background: Fecal microbiota transplantation (FMT) is a recommended treatment for recurrent Clostridioides difficile infection, and there is promise that FMT may be effective for conditions like inflammatory bowel disease (IBD). Previous FMT clinical trials have considered the possibility of a “donor effect”, that is, that FMT material from different donors has different clinical efficacies. Aim & Methods: Here we re-evaluate evidence for donor effects in published FMT clinical trials for IBD. Results: In 7 of 9 published studies, no statistically significant donor effect was detected when rigorously re-evaluating the original analyses. One study had statistically significant separation of microbiota composition of pools of donor stool when stratified by patient outcome. One study reported a significant effect but did not have underlying data available for re-evaluation. When quantifying the uncertainty on the magnitude of the donor effect, confidence intervals were large, including both zero donor effect and very substantial donor effects. Conclusion: Although we found very little evidence for donor effects, the existing data also cannot rule out the possibility that donor effects are clinically important. Large clinical trials prospectively designed to detect donor effects are likely necessary to determine if donor effects are clinically relevant for IBD.Keywords
All Related Versions
- Published version: Journal of Crohn's and Colitis, 15 (3), 453.
This publication has 45 references indexed in Scilit:
- Global disparities in faecal microbiota transplantation researchThe Lancet Gastroenterology & Hepatology, 2020
- Fecal transplantation for ulcerative colitis: current evidence and future applicationsExpert Opinion on Biological Therapy, 2020
- The evolution of the use of faecal microbiota transplantation and emerging therapeutic indicationsThe Lancet, 2019
- The Super-Donor Phenomenon in Fecal Microbiota TransplantationFrontiers in Cellular and Infection Microbiology, 2019
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clinical Infectious Diseases, 2018
- The gut microbiota and host health: a new clinical frontierGut, 2015
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative ColitisGastroenterology, 2015
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patientsClinical Microbiology and Infection, 2014
- Diet rapidly and reproducibly alters the human gut microbiomeNature, 2013
- The Human Microbiome ProjectNature, 2007